| Fritsche, Andreas |
| Recruiting | 2 | 150 | Europe | Bromocriptine, Placebo | University Hospital Tuebingen, University Hospital of Cologne, University Hospital Lübeck | Obesity | 12/24 | 06/25 | | |
NCT02991365: Effect of Weight Loss on Brain Insulin Sensitivity in Humans |
|
|
| Recruiting | N/A | 40 | Europe | nasal insulin, placebo spray | University Hospital Tuebingen | Insulin Resistance | 09/24 | 12/24 | | |
| Recruiting | N/A | 200 | Europe | Intermittent fasting, Control diet | University Hospital Tuebingen, German Institute of Human Nutrition, Charite University, Berlin, Germany, University Hospital Carl Gustav Carus, University of Leipzig, Ludwig-Maximilians - University of Munich, University Hospital Heidelberg, University of Luebeck, German Diabetes-Center, Leibniz-Institut in Düsseldorf, German Center for Diabetes Research | PreDiabetes, Diabetes type2, Intermittent Fasting, Insulin Secretion | 12/24 | 03/25 | | |
NCT04272411: SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism |
|
|
| Completed | N/A | 10 | Europe | Sham SCS stimulation, Tonic SCS stimulation, Burst SCS Stimulation | University Hospital Tuebingen, Abbott | Spinal Cord Stimulation (SCS), Blood Glucose Metabolism, Euglycemic Hyperinsulinemic Clamp | 11/19 | 06/20 | | |
NCT04314167: Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion |
|
|
| Terminated | N/A | 9 | Europe | Lowering cholesterol concentrations by PCSK-9 inhibitor | University Hospital Tuebingen | Hypercholesterolemia, Insulin Resistance, Insulin Secretion | 03/24 | 03/24 | | |
NCT05794776: Effect of Spinal Cord Stimulation (SCS) on Insulin Secretion in Humans |
|
|
| Withdrawn | N/A | 10 | Europe | BurstDR stimulation, Tonic stimulation, No stimulation, No spinal cord stimulation | University Hospital Tuebingen | Spinal Cord Stimulation, Insulin Secretion | 09/23 | 10/23 | | |
| Recruiting | N/A | 800 | Europe | | University Hospital Tuebingen, Deutsches Diabeteszentrum (DDZ), Leibniz-Institut Düsseldorf, Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, TU Dresden, Klinik für Diabetologie an der Medizinischen Klinik - Innenstadt, LMU München, Universitätsklinik Heidelberg, Abteilung Innere Medizin I, Schwerpunkt Endokrinologie und Stoffwechsel, Universitätsklinikum Leipzig, IFB Adipositas Erkrankungen | Gestational Diabetes | 05/27 | 05/28 | | |
| Recruiting | N/A | 1000 | Europe | | University Hospital Tuebingen | Diabetes Mellitus | 02/28 | 02/28 | | |
NCT04722900: PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes |
|
|
| Recruiting | N/A | 100 | Europe | intrauterine exposure to elevated glucose levels | University Hospital Tuebingen | Offspring Exposed to GDM and Control | 01/36 | 09/36 | | |
| Wagner, Robert J |
NCT06054035: SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes |
|
|
| Recruiting | 4 | 182 | Europe | Dapagliflozin (Forxiga®), Placebo matching Dapaglifolzin, Lifestyle Intervention | University Hospital Tuebingen, German Federal Ministry of Education and Research, German Center for Diabetes Research, AstraZeneca | Type2diabetes, PreDiabetes, Renal Failure | 03/26 | 12/26 | | |
NCT04467515: A Study to Evaluate Safety, Tolerability, Dosimetry, and Preliminary Efficacy of the HER2 Directed Radioligand CAM-H2 in Patients With Advanced/Metastatic HER2-Positive Breast, Gastric, and Gastro-Esophageal Junction (GEJ) Cancer |
|
|
| Terminated | 1/2 | 13 | Canada, US | CAM-H2 | Precirix | Advanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care Treatment | 12/23 | 12/23 | | |
| Heni, Martin |
| Active, not recruiting | 4 | 192 | Europe | Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector, Jardiance(R), Ozempic(R), Empagliflozin 10mg oral tablet and placebo pen injector matching semaglutide, Jardiance(R), Placebo matching empagliflozin and placebo pen injector matching semaglutide, Control / Placebo | German Diabetes Center, Boehringer Ingelheim, German Center for Diabetes Research, Federal Ministry of Health, Germany, Ministry of Innovation, Science and Research in North Rhine-Westphalia, Novo Nordisk A/S | Type 2 Diabetes, Non-alcoholic Steatohepatitis (NASH), Non-alcoholic Fatty Liver Disease (NAFLD) | 01/25 | 12/25 | | |
NCT02991365: Effect of Weight Loss on Brain Insulin Sensitivity in Humans |
|
|
| Recruiting | N/A | 40 | Europe | nasal insulin, placebo spray | University Hospital Tuebingen | Insulin Resistance | 09/24 | 12/24 | | |
| Recruiting | N/A | 30 | Europe | oral glucose tolerance test, circadian rhythm, effect of insulin on peptide transport | University Hospital Tuebingen | Obesity | 12/22 | 06/23 | | |
| Recruiting | N/A | 50 | Europe | Diet Modification Group, Regular Diet Group | University Hospital Tuebingen | Gestational Diabetes | 07/23 | 11/23 | | |
HypoCGM, NCT06182527: Relevance of Reactive Hypoglycemia During an OGTT in Everyday Life Using Continuous Glucose Measurement |
|
|
| Recruiting | N/A | 20 | Europe | Free Style Libre Pro IQ | University of Ulm | Hypoglycemia, Reactive | 02/25 | 03/25 | | |
| Recruiting | N/A | 30 | Europe | Oral glucose tolerance test with double-tracer dilution and intranasal insulin spray, Oral glucose tolerance test with double-tracer dilution and intranasal placebo spray | University of Ulm | Glucose Metabolism Disorders | 12/25 | 01/26 | | |
| Recruiting | N/A | 30 | Europe | Wearable | University of Ulm | Physiological Reactivity to Cues | 09/26 | 10/26 | | |
NCT06552130: The Importance of Insulin Action in the Brain for the Immune System During Physical Activity |
|
|
| Recruiting | N/A | 20 | Europe | Spiroergometer test with intranasal insulin spray, Spiroergometer test with intranasal placebo spray | University of Ulm | Insulin Sensitivity | 08/26 | 09/26 | | |
NCT06709846: Magnetic Resonance Imaging in Metabolic Diseases |
|
|
| Not yet recruiting | N/A | 126 | Europe | | University of Ulm | Metabolic Diseases | 12/29 | 12/29 | | |
| Kullmann, Stephanie |
NCT02991365: Effect of Weight Loss on Brain Insulin Sensitivity in Humans |
|
|
| Recruiting | N/A | 40 | Europe | nasal insulin, placebo spray | University Hospital Tuebingen | Insulin Resistance | 09/24 | 12/24 | | |
| Completed | N/A | 44 | Europe | transcranial direct current stimulation | University Hospital Tuebingen, German Center for Diabetes Research | Insulin Resistance, Transcranial Direct Current Stimulation, Obesity, Diabetes, Magnetic Resonance Imaging | 10/23 | 11/23 | | |
| Active, not recruiting | N/A | 40 | Europe | anodal transcranial direct current stimulation, anodal tDCS, excitatory tDCS, cathodal transcranial direct current stimulation, cathodal tDCS, inhibitory tDCS, sham transcranial direct current stimulation, sham tDCS | University Hospital Tuebingen | Insulin Resistance, Obesity, Diabetes Type 2 | 11/24 | 12/24 | | |
NCT06487832: Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness |
|
|
| Recruiting | N/A | 60 | Europe | Subcutaneous GLP1-RA, Subcutaneous placebo | University Hospital Tuebingen | Normal Weight, Overweight and Obesity, Insulin Sensitivity, Insulin Resistance | 07/27 | 12/27 | | |
| Recruiting | N/A | 40 | Europe | single bout of moderate intensity continuous training (MICT), single bout of High Intensity Interval Training (HIIT), waiting control | University Hospital Tuebingen | Insulin Resistance, Obesity | 12/26 | 12/26 | | |
| Vosseler, Andreas |
| No trials found |
| Willmann, Caroline |
| No trials found |
